PureHealth to acquire 60% of Hellenic Healthcare for US $2.3B

UAE – PureHealth Holding PJSC, the Middle East’s largest healthcare provider, has announced an agreement to acquire a 60% stake in Hellenic Healthcare Group (HHG) from CVC Capital Partners in a deal valued at €2.2 billion (US $2.3 billion).

The acquisition aligns with PureHealth’s global expansion strategy, aiming to diversify its revenue base and enhance operational efficiencies across international markets.

HHG stands as one of the leading private healthcare providers in Greece and Cyprus, operating a network of 10 hospitals and 16 diagnostic centers with a combined capacity of over 1,600 beds.

The group treats approximately 1.4 million patients annually and employs more than 6,700 healthcare professionals.

Its service portfolio spans critical specialties such as oncology, cardiology, neurosurgery, and in-vitro fertilization (IVF).

CVC Capital Partners, which currently holds a 90% stake in HHG, will retain a 35% share post-transaction, while HHG’s CEO, Dimitris Spyridis, will maintain his 5% ownership.

The new structure is expected to foster collaborative synergies between PureHealth, CVC, and HHG, enhancing both regional and global healthcare capabilities.

Strategic rationale

This deal marks PureHealth’s continued commitment to establishing itself as a global healthcare leader.

By integrating HHG’s high-performing network into its growing international portfolio, PureHealth aims to:

• Strengthen its European presence, particularly in advanced clinical services
• Leverage HHG’s operational expertise to raise care quality and innovation
• Accelerate value creation through cross-border collaboration and shared best practices

The acquisition follows PureHealth’s recent high-profile investments in global healthcare infrastructure and tech platforms.

It represents one of the most significant Middle Eastern healthcare investments in Europe to date. The transaction is subject to regulatory approvals and customary closing conditions.

Upon completion, the combined strength of HHG’s market leadership in Southern Europe and PureHealth’s scale and technological capabilities is expected to create a powerful growth platform positioned to redefine cross-border healthcare delivery.

PureHealth group CEO Shaista Asif said: “This move aligns with our vision of becoming a global leader in healthcare, with more than 50% of our revenues originating outside the GCC.”